Agfa HealthCare designed its next-generation PACS, the IMPAX 6.0, to meet the specific workflow requirements of multiple users. Introduced at the RSNA meeting, the IMPAX 6.0 is a Web-deployable application that improves the planning, capture, interpretation, distribution, and archiving of images throughout an enterprise, according to the company.
Agfa HealthCare designed its next-generation PACS, the IMPAX 6.0, to meet the specific workflow requirements of multiple users. Introduced at the RSNA meeting, the IMPAX 6.0 is a Web-deployable application that improves the planning, capture, interpretation, distribution, and archiving of images throughout an enterprise, according to the company.
Agfa integrated the IMPAX 6.0 with its IMPAX RIS to optimize clinical and IT efficiencies. A single workflow-based system serves users both within and outside a facility, consolidating the management of patient images and information.
In developing the IMPAX 6.0, Agfa consulted with IT and management experts who indicated a need for technology that reflects individual user preferences as much as basic archival needs. Agfa built the IMPAX 6.0 around common work behaviors of six identified target user groups: healthcare administrators, radiologists, PACS administrators, technologists, clinicians, and IT specialists.
IMPAX 6.0 features, navigation tools, and display modes were designed in flexible and intuitive fashion to tailor them to the individual preferences within these groups. Essentially, users can match applications to their chosen work habits.
The system is more user-friendly than its predecessors, and its intuitive interface reduces training time, according to the company. Because the system is centrally managed, IMPAX 6.0 makes it easier to deploy solutions, manage users, provide support, and configure permissions and roles.
The company claims that users may experience greater time efficiencies and achieve higher job satisfaction levels because the IMPAX 6.0 makes it possible for them to perform their specific functions with greater confidence.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.